IQVIA™ Real-World Insights Bibliography

Cost-utility model for 2nd generation treatment of chronic HCV in general population: impact of EASL recommendations in 2016 and 2018
Author(s): Nat?lia Pascual-Argent? (1,2); Carlos Crespo (1,3); Laura Planellas (4); M?riam Solozabal (4), N?ria Perulero (4); Jaume Puig-Junoy (1,2)
Affiliations(s): (1) UPF Barcelona School of Management; (2) Dept. Econom?a y Empresa ? CRES UPF; (3) Universitat de Barcelona; (4) HEOR-RWE, IQVIA Spain
Publication(s):  XXXIX Jornadas de Econom?a de la Salud. Albacete, 12 al 14 de junio de 2019
Document Type(s): Poster,
Countries: Spain,
Click here for the abstract
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Health economics, Infectious disease,
2019
  L:
A:
Spanish
Clinical setting: hospital, Cost effectiveness,
  Add to report
 
 
Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for systemic candida infections in China
Author(s): Dechang Chen, Xianyao Wan, Eliza Kruger, Can Chen, Xiaomeng Yue, Liang Wang, Jiuhong Wu
Affiliations(s): IQVIA, Department of Critical Care Medicine, Shanghai Ruijin Hospital Affiliated To Jiaotong University, School of Medicine, Shanghai
Publication(s):  Journal of Medical Economics
Document Type(s): Article,
Countries: China,
Click here for the abstract
C:
Y:
Health economics, Infectious disease,
2018
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
A cost?benefit analysis of smoking cessation prescription coverage from a US payer perspective
Author(s): Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P. A
Affiliations(s): Baker, Subedi: Pfizer; Ferrufino, Kowal and Tan: IQVIA
Publication(s):  ClinicoEconomics and outcomes research
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Health economics,
2018
  L:
A:
English
Cost benefit,
  Add to report
 
 
The Effect of Medicare's Annual Wellness Visit on Preventive Care for the Elderly
Author(s): Miao Jiang; Danny Hughes; Wenyi Wang
Affiliations(s): Miao Jiang (IQVIA); Danny Hughes (Georgia Tech and Neiman HPI); Wenyi Wang (Medstar)
Publication(s):  Preventive Medicine
Document Type(s): Article,
Countries: USA,
C:
Y:
Health economics, Health policy,
2018
  L:
A:
English
Observational study, Population Based Study, Public Health, Retrospective cohort analysis,
  Add to report
 
 
A retrospective study to assess resource utilization and costs in patients with post-stroke spasticity in the United Kingdom
Author(s): Raluy-Callado M, Cox A, MacLachlan S, Bakheit AM, Moore AP, Dinet J & Gabriel S
Affiliations(s): Evidera
Publication(s):  Current Medical Research and Opinion
Document Type(s): Article,
Countries: UK,
C:
Y:
Health economics,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Assessing and modeling organizational impact of tilmanocept in performing sentinel lymph node biopsy in France
Author(s): Clément Le Dissez1, Pascal Paubel2, Frédéric Courbon3, Rémy Herve4, Mark Rance5, Marie-Aude Courteille6
Affiliations(s): 1IQVIA Opération France, Paris, La Défense ; 2Inserm UMR S 1145, Institut Droit et Santé, faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, 4 avenue de l’observatoire, 75006 Paris, France ; 3 Department of Medical Imaging, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France ; 4 Department of Pharmacy, Institute of Cancerology Gustave Roussy, University of Paris-Sud, Villejuif, France ; 5Norgine, Corporate ; 6Norgine, France
Publication(s): 
Document Type(s): Poster,
Countries: France,
C:
Y:
Clinical practice, Health economics, Oncology,
2018
  L:
A:
English
Budget impact, Literature Review, Public Health,
  Add to report
 
 
LIMITATIONS AND EXPECTED CHALLENGES OF CAR-T ECONOMIC EVALUATION.
Author(s): Allou A*, Carette J*, Minacori R*, Touahmia S*, Bourguignon S*, Troubat A*, Maurel F*
Affiliations(s): IQVIA France - RWI
Publication(s):  ISPOR 2018
Document Type(s): Poster,
Countries: France,
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Health economics, Hematology,
2018
  L:
A:
English
Cost effectiveness, Market impact, Review,
  Add to report
 
 
WHAT INTERPRETATION OF ICERS IN ORPHAN DISEASES? A FRENCH EXAMPLE.
Author(s): Moutier Hélène; Bourguignon Sandrine; Maurel Frédérique; Bodaghi Charles
Affiliations(s): RWI IQVIA France
Publication(s):  ISPOR 2018
Document Type(s): Poster,
Countries: France,
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Health economics, Pricing and reimbursement, Rare Diseases,
2018
  L:
A:
English
Cost effectiveness, Pricing & Reimbursement, Willingness to pay,
  Add to report
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.
Author(s): Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5
Affiliations(s): 1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France
Publication(s):  European Society of Cardiology (ESC) Congress, 2018, Munich, Germany
Document Type(s): Poster,
Countries: Belgium, France, Poland, Portugal, Spain, Switzerland, UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2018
  L:
A:
English
Burden of illness, Cost of illness,
  Add to report
 
 
Patient and caregiver indirect costs after acute cardiovascular events in Europe.
Author(s): Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5
Affiliations(s): 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium
Publication(s):  ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Type(s): Oral presentation,
Countries: Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2018
  L:
A:
English
Burden of illness, Cost of illness,
  Add to report
 
 
 1 of 18 Next Page Last Page